Page 6 - Forefront Analytics News Today

ALX Oncology Holdings Inc. (NASDAQ:ALXO – Get Free Report) dropped 4% during mid-day trading on Monday . The company traded as low as $14.51 and last traded at $14.60. Approximately 21,076 shares were traded during trading, a decline of 94% from the average daily volume of 330,813 shares. The stock had previously closed at $15.21. […]

Shares of ALX Oncology Holdings Inc. (NASDAQ:ALXO – Get Free Report) have been assigned a consensus recommendation of “Buy” from the eight ratings firms that are presently covering the stock, MarketBeat reports. Eight research analysts have rated the stock with a buy recommendation. The average twelve-month price objective among analysts that have issued ratings on […]

CHI Advisors LLC boosted its holdings in shares of Orchard Therapeutics plc (NASDAQ:ORTX – Free Report) by 1,529.6% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 12,315,654 shares of the company’s stock after acquiring an additional 11,559,916 shares during the quarter. Orchard Therapeutics accounts […]

Silverarc Capital Management LLC boosted its holdings in Annexon, Inc. (NASDAQ:ANNX – Free Report) by 2.5% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 399,716 shares of the company’s stock after purchasing an additional 9,805 shares during the quarter. Silverarc Capital Management LLC […]

Western Wealth Management LLC reduced its holdings in shares of iShares Floating Rate Bond ETF (BATS:FLOT – Free Report) by 3.4% in the third quarter, HoldingsChannel reports. The fund owned 18,860 shares of the company’s stock after selling 659 shares during the period. Western Wealth Management LLC’s holdings in iShares Floating Rate Bond ETF were […]

Banco Santander S.A. boosted its stake in iShares Floating Rate Bond ETF (BATS:FLOT – Free Report) by 56.8% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 78,649 shares of the company’s stock after purchasing an additional 28,488 shares during the […]

Forefront Analytics LLC trimmed its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 14.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 293 shares of the biopharmaceutical company’s stock after selling 48 shares during the quarter. Forefront Analytics LLC’s […]

Forefront Analytics LLC grew its position in shares of iShares MSCI USA Min Vol Factor ETF (BATS:USMV – Free Report) by 11.5% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 11,567 shares of the company’s stock after buying an additional 1,197 shares during […]

Forefront Analytics LLC grew its position in Vanguard Value ETF (NYSEARCA:VTV – Free Report) by 4.3% during the 3rd quarter, HoldingsChannel reports. The firm owned 11,412 shares of the company’s stock after purchasing an additional 475 shares during the quarter. Vanguard Value ETF comprises about 0.9% of Forefront Analytics LLC’s portfolio, making the stock its […]

Forefront Analytics LLC bought a new stake in Orchard Therapeutics plc (NASDAQ:ORTX – Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 14,183 shares of the company’s stock, valued at approximately $110,000. Forefront Analytics LLC owned 0.06% […]